Spartan Planning & Wealth Management Abbott Laboratories Transaction History
Spartan Planning & Wealth Management
- $89.6 Million
- Q4 2023
A detailed history of Spartan Planning & Wealth Management transactions in Abbott Laboratories stock. As of the latest transaction made, Spartan Planning & Wealth Management holds 1,160 shares of ABT stock, worth $130,198. This represents 0.14% of its overall portfolio holdings.
Number of Shares
1,160Holding current value
$130,198% of portfolio
0.14%Shares
3 transactions
Others Institutions Holding ABT
# of Institutions
3,138Shares Held
1.33BCall Options Held
8.63MPut Options Held
7.17M-
Vanguard Group Inc Valley Forge, PA166MShares$18.7 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$14.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA74.4MShares$8.35 Billion0.34% of portfolio
-
Capital International Investors Los Angeles, CA71.8MShares$8.06 Billion1.57% of portfolio
-
Capital Research Global Investors Los Angeles, CA57.2MShares$6.42 Billion1.34% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $197B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...